专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO2016110821A1 BICYCLIC COMPOUNDS, COMPOSITIONS AND MEDICINAL APPLICATIONS THEREOF 审中-公开
标题翻译：双组分化合物，组合物和药物应用
公开(公告)号：WO2016110821A1
公开(公告)日：2016-07-14
申请号：PCT/IB2016/050078
申请日：2016-01-08
申请人： ADVINUS THERAPEUTICS LIMITED
发明人： MUKHOPADHYAY, Partha , MUNOT, Yogesh , SHAIKH, Nadim , KULKARNI, Bheemashankar A. , MOOKHTIAR, Kasim
IPC分类号： C07D471/04 , A61K31/437 , A61P29/00
CPC分类号： C07D471/04 , A61K31/437 , A61K31/5377
摘要： The present disclosure relates to a class of substituted bicyclic compounds of formula (I), their tautomers, polymorphs, stereoisomers, prodrugs, solvates, hydrates, N-oxides, co-crystals, pharmaceutically acceptable salts and pharmaceutical compositions containing them. The disclosure also relates to the process of preparation of compounds of Formula (I). These compounds are useful in the treatment, prevention, prophylaxis, management, or adjunct treatment of all medical conditions related to inhibition of retinoic acid-related orphan receptor gamma (RORγ) such as inflammatory and/or autoimmune disorder, rheumatoid arthritis, psoriasis, psoriatic arthritis, multiple sclerosis, inflammatory bowel disease, allergic diseases, asthma, COPD, cancer, cell proliferation, type 1 diabetes, myasthenia gravis, hematopoetic disfunction, systemic lupus, erythematosus or other disorders.
摘要翻译：本公开涉及一类式（I）的取代双环化合物，其互变异构体，多晶型物，立体异构体，前药，溶剂合物，水合物，N-氧化物，共晶体，药学上可接受的盐和含有它们的药物组合物。本公开还涉及制备式（I）化合物的方法。这些化合物可用于治疗，预防，预防，治疗或辅助治疗与视黄酸相关的孤儿受体γ（RORγ）的抑制相关的所有医学病症，例如炎性和/或自身免疫性疾病，类风湿性关节炎，牛皮癣，牛皮癣关节炎，多发性硬化症，炎性肠病，过敏性疾病，哮喘，COPD，癌症，细胞增殖，1型糖尿病，重症肌无力，造血功能障碍，系统性红斑狼疮，红斑狼疮或其他疾病。

2. 发明申请

WO2013157022A1 SUBSTITUTED HETERO-BICYCLIC COMPOUNDS, COMPOSITIONS AND MEDICINAL APPLICATIONS THEREOF 审中-公开
标题翻译：取代的异双环化合物，其组合物和药物应用
公开(公告)号：WO2013157022A1
公开(公告)日：2013-10-24
申请号：PCT/IN2013/000259
申请日：2013-04-18
申请人： ADVINUS THERAPEUTICS LIMITED
发明人： THAKKAR, Mahesh , KOUL, Summon , BHUNIYA, Debnath , MOOKHTIAR, Kasim , KURHADE, Santosh , MUNOT, Yogesh
IPC分类号： C07D413/14 , A61K31/519 , C07D403/14 , A61P19/02
CPC分类号： C07D519/00 , A61K31/519 , A61K31/5377 , A61K31/553 , A61K45/06 , C07D403/14 , C07D413/14 , C07D471/04 , C07D487/04
摘要： The present disclosure provides hetero-biclyclic compounds of formula (I), their tautomers, polymorphs, stereoisomers, prodrugs, solvates, hydrates, N-oxides, co-crystals, pharmaceutically acceptable salts, pharmaceutical compositions containing them and methods of treating conditions and diseases that are mediated by Bruton's tyrosine kinase (Btk) activity, The disclosure also relates to the process of preparation of compounds of Formula (I). These compounds are useful in the treatment, prevention, prophylaxis, management, or adjunct treatment of all medical conditions related to inhibition of Bruton's tyrosine kinase (Btk), such as inflammatory and/or autoimmune disorder, cell proliferation, rheumatoid arthritis, psoriasis, psoriatic arthritis, transplant rejection, graft-versus-host disease, multiple sclerosis, inflammatory bowel disease, allergic diseases, asthma, type 1 diabetes, myasthenia gravis, hematopoetic disfunction, B-cell malignancies, systemic lupus, erythematosus or other disorders.
摘要翻译：本公开提供了式（I）的异双二价化合物，其互变异构体，多晶型物，立体异构体，前药，溶剂合物，水合物，N-氧化物，共晶体，药学上可接受的盐，含有它们的药物组合物和治疗病症和疾病的方法这是由Bruton的酪氨酸激酶（Btk）活性介导的。本公开还涉及式（I）化合物的制备方法。这些化合物可用于治疗，预防，预防，治疗或辅助治疗与抑制Bruton酪氨酸激酶（Btk）相关的所有医学病症，如炎性和/或自身免疫性疾病，细胞增殖，类风湿性关节炎，牛皮癣，牛皮癣关节炎，移植排斥反应，移植物抗宿主病，多发性硬化症，炎性肠病，过敏性疾病，哮喘，1型糖尿病，重症肌无力，造血功能障碍，B细胞恶性肿瘤，系统性红斑狼疮，红斑狼疮或其他疾病。

3. 发明申请

WO2016128908A1 BICYCLIC COMPOUNDS, COMPOSITIONS AND MEDICINAL APPLICATIONS THEREOF 审中-公开
标题翻译：双组分化合物，组合物和药物应用
公开(公告)号：WO2016128908A1
公开(公告)日：2016-08-18
申请号：PCT/IB2016/050698
申请日：2016-02-10
申请人： ADVINUS THERAPEUTICS LIMITED
发明人： SHAIKH, Nadim , MUKHOPADHYAY, Partha , MUNOT, Yogesh , KULKARNI, Bheemashankar A. , MOOKHTIAR, Kasim
IPC分类号： C07D231/54 , C07D231/56 , C07D401/04 , C07D401/06 , C07D403/06 , A61K31/416 , A61P29/00 , A61P37/00
CPC分类号： C07D231/56 , C07D231/54 , C07D401/04 , C07D401/06 , C07D403/06
摘要： The present disclosure relates to a class of substituted bicyclic compounds of formula (I), their tautomers, polymorphs, stereoisomers, prodrugs, solvates, hydrates, N-oxides, co- crystals, pharmaceutically acceptable salts and pharmaceutical compositions containing them. The disclosure also relates to the process of preparation of compounds of Formula (I). (I) These compounds are useful in the treatment, prevention, prophylaxis, management, or adjunct treatment of all medical conditions related to inhibition of of retinoic acid-related orphan receptor gamma (ROR Ƴ ) such as inflammatory and/or autoimmune disorder, rheumatoid arthritis, psoriasis, psoriatic arthritis, multiple sclerosis, inflammatory bowel disease, allergic diseases, asthma, COPD, cancer, cell proliferation, type 1 diabetes, myasthenia gravis, hematopoetic disfunction, systemic lupus, erythematosus or other disorders.
摘要翻译：本公开涉及一类式（I）的取代双环化合物，其互变异构体，多晶型物，立体异构体，前药，溶剂合物，水合物，N-氧化物，共晶体，药学上可接受的盐和含有它们的药物组合物。本公开还涉及制备式（I）化合物的方法。（I）这些化合物可用于治疗，预防，预防，治疗或辅助治疗与抑制视黄酸相关的孤儿受体γ（RORƳ）相关的所有医学病症，如炎性和/或自身免疫性疾病，类风湿病关节炎，牛皮癣，牛皮癣关节炎，多发性硬化，炎性肠病，过敏性疾病，哮喘，COPD，癌症，细胞增殖，1型糖尿病，重症肌无力，造血功能障碍，系统性红斑狼疮，红斑狼疮或其他疾病。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式